Willingness to Use Pre-exposure Prophylaxis (PrEP) and Preferences Among Men Who have Sex with Men in Mumbai and Chennai, India: A Discrete Choice Experiment.
Pre-exposure prophylaxis (PrEP) programs are planned for key populations in India. We examined PrEP awareness and willingness to use PrEP in order to support products and services for MSM. From December 2016 to March 2017, we conducted a survey and discrete choice experiment (DCE)—a technique to qua...
| Publicado en: | AIDS & Behavior Vol. 25; no. 10; pp. 3074 - 3085 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | pictorial research tables/charts Journal Article |
| Publicado: |
Springer Nature
Oct2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=152251182&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 152251182 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10907165 G1T jtl: AIDS & Behavior issn: 10907165 maglogo: N pubinfo: dt: Oct2021 vid: 25 iid: 10 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 152251182 149658491 152251182 152251182 10.1007/s10461-021-03253-5 152251182 ppf: 3074 ppct: 11 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Willingness to Use Pre-exposure Prophylaxis (PrEP) and Preferences Among Men Who have Sex with Men in Mumbai and Chennai, India: A Discrete Choice Experiment. aug: au: Chakrapani, Venkatesan Newman, Peter A. Cameron, Michael Shunmugam, Murali Roungprakhon, Surachet Rawat, Shruta Baruah, Dicky Nelson, Ruban Tepjan, Suchon Scarpa, Riccardo affil: Centre for Sexuality and Health Research and Policy (C-SHaRP), Chennai, India sug: subj: HIV Infections Prevention and Control Pre-Exposure Prophylaxis Men Who Have Sex With Men Psychosocial Factors Attitude to Medical Treatment Evaluation Patient Preference Evaluation Human India Male Multiple Logistic Regression Descriptive Statistics Odds Ratio Confidence Intervals Anti-Retroviral Agents Administration and Dosage Hospitals, Public Anti-Retroviral Agents Economics Anti-Retroviral Agents Adverse Effects Male ab: Pre-exposure prophylaxis (PrEP) programs are planned for key populations in India. We examined PrEP awareness and willingness to use PrEP in order to support products and services for MSM. From December 2016 to March 2017, we conducted a survey and discrete choice experiment (DCE)—a technique to quantify the strength of participants' trade-off preferences among various product attributes—to assess willingness to use PrEP and related preferences. MSM were recruited from cruising sites and HIV prevention services in Mumbai and Chennai. DCE data were analyzed using mixed logit regression models and estimated marginal willingness-to-pay, the relative value participants' place on different PrEP attributes. Overall, 76.6% indicated willingness to use PrEP. Efficacy had the greatest effect on choice (high vs. moderate, aOR = 19.9; 95% CI 13.0–30.4), followed by dosing frequency (intermittent vs. daily regimen, aOR = 2.02; 95% CI 1.8–2.2). Participants preferred no (vs. minor) side-effects, subsidized (vs. market) price, and government (vs. private) hospitals. Findings suggest that educational and social marketing interventions should emphasize PrEP's high efficacy and minimal side effects, and programs should provide government-subsidized PrEP with choices of intermittent or daily dosing delivered by government and private hospitals/clinics in order to optimize PrEP uptake among MSM in India. pubtype: Academic Journal doctype: pictorial research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|